BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24390757)

  • 1. Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?
    de Jesús GR; Rodrigues G; de Jesús NR; Levy RA
    Curr Rheumatol Rep; 2014 Feb; 16(2):403. PubMed ID: 24390757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy and Antiphospholipid Syndrome.
    Schreiber K; Hunt BJ
    Semin Thromb Hemost; 2016 Oct; 42(7):780-788. PubMed ID: 27652601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
    Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
    Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome.
    Xi F; Cai Y; Lv M; Jiang Y; Zhou F; Chen Y; Jiang L; Luo Q
    Clin Appl Thromb Hemost; 2020; 26():1076029620974455. PubMed ID: 33296221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
    Li XY; Zhao JX; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):956-961. PubMed ID: 30562764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
    Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
    Hoppe B; Burmester GR; Dörner T
    Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid syndrome in obstetrics.
    Heilmann L; von Tempelhoff GF; Pollow K
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):143-50. PubMed ID: 12812384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome in obstetrics.
    Kemp M; Thomas W
    Lupus; 2018 Oct; 27(1_suppl):28-31. PubMed ID: 30452326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity: effectiveness of treatments for pregnant women with APS.
    Gelber SE; Salmon JE
    Nat Rev Rheumatol; 2010 Apr; 6(4):187-9. PubMed ID: 20357787
    [No Abstract]   [Full Text] [Related]  

  • 15. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibody syndrome.
    Kutteh WH; Hinote CD
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome in pregnancy.
    Carp HJ
    Curr Opin Obstet Gynecol; 2004 Apr; 16(2):129-35. PubMed ID: 15017341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding and Preventing Placenta-Mediated Pregnancy Complications.
    Skeith L; Blondon M; Ní Áinle F
    Hamostaseologie; 2020 Aug; 40(3):356-363. PubMed ID: 32726830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of pregnant patients with antiphospholipid syndrome.
    Cervera R; Balasch J
    Lupus; 2004; 13(9):683-7. PubMed ID: 15485103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome and pregnancy loss.
    Rai R; Regan L
    Hosp Med; 1998 Aug; 59(8):637-9. PubMed ID: 9829058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.